Mars Chocolate North America introduced the Marathon Smart Stuff bar, a snacking solution that contains such healthful ingredients as dried fruits and nuts, and is fortified with a blend of eight essential vitamins and minerals.
Nestlé HealthCare Nutrition on Tuesday announced a new look for its venerable Boost nutritional beverage line featuring a grip-friendly bottle design that is lightweight and a no-foil, easy-to-open top.
Watson Pharmaceuticals last week confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex, Mucinex D and Mucinex DM extended-release products do not infringe Reckitt Benckiser’s U.S. Patent No. 6,372,252.
Product recalls over the past two years have eroded consumer trust in over-the-counter drugs; however, those same recalls represent opportunity for smaller market players to gain exposure and build brand awareness, wrote Laura Mahecha, industry manager for health care at research firm Kline, in an online report issued Wednesday.
Mars Chocolate North America announced that it is commemorating the final mission of Space Shuttle Atlantis by providing the crew — as well as NASA personnel at both launch control Kennedy Space Center in Cape Canaveral and mission control at Johnson Space Center in Houston — with personalized versions of its M&M’S brand candy.
Johnson & Johnson on Thursday announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil, becoming the eighth and final FIFA World Cup Sponsor.
Grocer A&P has announced the launch of a new Preferred Pet Club program in collaboration with the American Society for the Prevention of Cruelty to Animals, offering exclusive discounts to pet owners across New York, New Jersey, Pennsylvania, Delaware and Connecticut.
Pharmacy benefit manager Medco Health Solutions’ specialty pharmacy division, Accredo Health Group, has managed to drive down costs for treating hepatitis C by an average of $13,000 per patient, the company said Tuesday.